2024 Q2 Form 10-Q Financial Statement

#000187901624000009 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $538.0K $360.0K
YoY Change -59.06% -46.98%
Cost Of Revenue $192.0K $100.0K
YoY Change -84.71% -45.65%
Gross Profit $346.0K $260.0K
YoY Change 496.55% -47.47%
Gross Profit Margin 64.31% 72.22%
Selling, General & Admin $10.80M $12.69M
YoY Change -15.35% 18.78%
% of Gross Profit 3120.23% 4880.0%
Research & Development $842.0K $810.0K
YoY Change -60.62% -56.05%
% of Gross Profit 243.35% 311.54%
Depreciation & Amortization $713.0K $622.0K
YoY Change 5.79% -40.19%
% of Gross Profit 206.07% 239.23%
Operating Expenses $11.64M $13.50M
YoY Change -21.85% 7.77%
Operating Profit -$48.55M -$56.88M
YoY Change 2.45% 47.4%
Interest Expense -$387.0K $1.816M
YoY Change -129.45% -325.87%
% of Operating Profit
Other Income/Expense, Net -$12.00K $3.000K
YoY Change -101.09% -99.6%
Pretax Income -$51.52M -$60.12M
YoY Change 14.55% 55.54%
Income Tax $0.00 -$26.00K
% Of Pretax Income
Net Earnings -$51.52M -$60.10M
YoY Change 14.88% 55.77%
Net Earnings / Revenue -9576.39% -16693.06%
Basic Earnings Per Share $0.39 $0.46
Diluted Earnings Per Share $0.39 $0.46
COMMON SHARES
Basic Shares Outstanding 120.3M shares 120.3M shares
Diluted Shares Outstanding 120.3M shares 120.2M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $133.8M $179.4M
YoY Change 109.73% 67.63%
Cash & Equivalents $133.8M $179.4M
Short-Term Investments
Other Short-Term Assets $5.070M $2.853M
YoY Change -15.17% -7.52%
Inventory $5.507M $5.313M
Prepaid Expenses
Receivables $2.618M $4.319M
Other Receivables $0.00 $0.00
Total Short-Term Assets $147.0M $191.8M
YoY Change 92.07% 62.37%
LONG-TERM ASSETS
Property, Plant & Equipment $8.955M $7.823M
YoY Change 124.6% 85.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.45M $38.97M
YoY Change 265.25% 401.22%
Other Assets $5.697M $5.698M
YoY Change -35.79% -30.15%
Total Long-Term Assets $269.3M $269.3M
YoY Change 15.45% 146.6%
TOTAL ASSETS
Total Short-Term Assets $147.0M $191.8M
Total Long-Term Assets $269.3M $269.3M
Total Assets $416.3M $461.2M
YoY Change 34.39% 102.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.41M $22.29M
YoY Change -10.21% 72.37%
Accrued Expenses $1.136M $623.0K
YoY Change 47.92% -25.03%
Deferred Revenue $2.700M $2.500M
YoY Change -3.57% -30.56%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $14.96M $13.82M
YoY Change -57.35%
Total Short-Term Liabilities $40.20M $39.21M
YoY Change -35.69% 126.19%
LONG-TERM LIABILITIES
Long-Term Debt $65.84M $65.23M
YoY Change -12.52% 146.82%
Other Long-Term Liabilities $594.0K $580.0K
YoY Change -22.56% 1218.18%
Total Long-Term Liabilities $594.0K $580.0K
YoY Change -22.56% 1218.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.20M $39.21M
Total Long-Term Liabilities $594.0K $580.0K
Total Liabilities $113.1M $111.4M
YoY Change -20.88% 91.17%
SHAREHOLDERS EQUITY
Retained Earnings -$503.8M -$457.0M
YoY Change 82.23% 91.86%
Common Stock $795.5M $790.8M
YoY Change 81.02% 90.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $289.2M $331.5M
YoY Change
Total Liabilities & Shareholders Equity $416.3M $461.2M
YoY Change 34.39% 102.82%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$51.52M -$60.10M
YoY Change 14.88% 55.77%
Depreciation, Depletion And Amortization $713.0K $622.0K
YoY Change 5.79% -40.19%
Cash From Operating Activities -$44.54M -$49.96M
YoY Change 24.38% 66.42%
INVESTING ACTIVITIES
Capital Expenditures $844.0K $672.0K
YoY Change -97.76% 93.1%
Acquisitions
YoY Change
Other Investing Activities -$405.0K -$495.0K
YoY Change -32.84% -10.81%
Cash From Investing Activities -$1.249M -$1.467M
YoY Change -96.73% -44.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.074M $26.00M
YoY Change -96.5% 866566.67%
NET CHANGE
Cash From Operating Activities -44.54M -$49.96M
Cash From Investing Activities -1.249M -$1.467M
Cash From Financing Activities 1.074M $26.00M
Net Change In Cash -44.72M -$25.68M
YoY Change 3.11% -21.38%
FREE CASH FLOW
Cash From Operating Activities -$44.54M -$49.96M
Capital Expenditures $844.0K $672.0K
Free Cash Flow -$45.39M -$50.63M
YoY Change -38.18% 66.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120000000.0 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120300000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120300000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120000000.0 shares
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
100000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
184000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
260000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
495000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
43643000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
26559000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12601000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10633000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
810000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1843000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
87000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-56881000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-38589000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
32000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
5000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
161000 usd
CY2024Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
-271000 usd
CY2023Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
-375000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3012000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-622000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
741000 usd
CY2024Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-60121000 usd
CY2023Q1 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-38652000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-72000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-60095000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38580000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4584000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2506000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-55511000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36074000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-60095000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38580000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-392000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-68000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-392000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-68000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-60487000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-38648000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-55761000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36120000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4726000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2528000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-60487000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-38648000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120246430 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120246430 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
92964249 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92964249 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
202447000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38580000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-68000 usd
CY2023Q1 ie Stock Issued During Period Value New Issues Earn In Payment
StockIssuedDuringPeriodValueNewIssuesEarnInPayment
150000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5132000 usd
CY2023Q1 ie Adjustments To Noncontrolling Interest Other
AdjustmentsToNoncontrollingInterestOther
-2000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
169082000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
376281000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-60095000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-392000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
952000 usd
CY2024Q1 ie Stock Issued During Period Value New Issues Earn In Payment
StockIssuedDuringPeriodValueNewIssuesEarnInPayment
95000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3345000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
30000000 usd
CY2024Q1 ie Adjustments To Noncontrolling Interest Other
AdjustmentsToNoncontrollingInterestOther
-454000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
349732000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-60095000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38580000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
622000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1040000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3345000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5132000 usd
CY2024Q1 ie Non Cash Payments To Explore Oil And Gas Properties
NonCashPaymentsToExploreOilAndGasProperties
-209000 usd
CY2023Q1 ie Non Cash Payments To Explore Oil And Gas Properties
NonCashPaymentsToExploreOilAndGasProperties
-662000 usd
CY2024Q1 ie Non Cash Payments For Research And Development
NonCashPaymentsForResearchAndDevelopment
-282000 usd
CY2023Q1 ie Non Cash Payments For Research And Development
NonCashPaymentsForResearchAndDevelopment
-645000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
3000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
155000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1816000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
804000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-72000 usd
CY2024Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
-271000 usd
CY2023Q1 us-gaap Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount
DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount
-375000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3012000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-622000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
350000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-141000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
896000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
710000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
309000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
144000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-350000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-283000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1435000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1108000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-352000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1894000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49959000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30019000 usd
CY2024Q1 ie Payments To Acquire Mineral Interest Rights
PaymentsToAcquireMineralInterestRights
300000 usd
CY2023Q1 ie Payments To Acquire Mineral Interest Rights
PaymentsToAcquireMineralInterestRights
1763000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
672000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
348000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
722000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
555000 usd
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
227000 usd
CY2023Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1467000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2666000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
26000000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-256000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25682000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32665000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205043000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
139660000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
179361000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106995000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1069000 usd
CY2024Q1 ie Issuance Of Common Stock Kaizen Arrangement
IssuanceOfCommonStockKaizenArrangement
952000 usd
CY2023Q1 ie Issuance Of Common Stock Kaizen Arrangement
IssuanceOfCommonStockKaizenArrangement
0 usd
CY2024Q1 us-gaap Stock Issued1
StockIssued1
95000 usd
CY2023Q1 us-gaap Stock Issued1
StockIssued1
150000 usd
CY2024Q1 ie Non Controlling Interests Investment In Subsidiary Noncash
NonControllingInterestsInvestmentInSubsidiaryNoncash
4000000 usd
CY2023Q1 ie Non Controlling Interests Investment In Subsidiary Noncash
NonControllingInterestsInvestmentInSubsidiaryNoncash
0 usd
CY2024Q1 ie Settlement Of Related Party Loan
SettlementOfRelatedPartyLoan
-4000000 usd
CY2023Q1 ie Settlement Of Related Party Loan
SettlementOfRelatedPartyLoan
0 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
216290000 usd
CY2024Q1 us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
529000 usd
CY2024Q1 ie Mineral Properties Foreign Currency Translation Adjustments
MineralPropertiesForeignCurrencyTranslationAdjustments
5000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
216824000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
30200000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
15000000 usd
CY2023Q4 us-gaap Investments
Investments
39130000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
454000 usd
CY2024Q1 ie Payments To Acquire Equity Method Investments Including Non Cash Payment
PaymentsToAcquireEquityMethodInvestmentsIncludingNonCashPayment
722000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3012000 usd
CY2024Q1 ie Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
489000 usd
CY2024Q1 ie Investments Foreign Currency Translation
InvestmentsForeignCurrencyTranslation
-75000 usd
CY2024Q1 us-gaap Investments
Investments
36730000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
48916000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1145000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
50061000 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
13817000 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
36244000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
50061000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3345000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5132000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
360000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
679000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2500000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2400000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
43643000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
26559000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment

Files In Submission

Name View Source Status
0001879016-24-000009-index-headers.html Edgar Link pending
0001879016-24-000009-index.html Edgar Link pending
0001879016-24-000009.txt Edgar Link pending
0001879016-24-000009-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ie-20240331.htm Edgar Link pending
ie-20240331.xsd Edgar Link pending
ie-2024x03x31xex311.htm Edgar Link pending
ie-2024x03x31xex312.htm Edgar Link pending
ie-2024x03x31xex321.htm Edgar Link pending
ie-2024x03x31xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
ie-20240331_cal.xml Edgar Link unprocessable
ie-20240331_lab.xml Edgar Link unprocessable
ie-20240331_pre.xml Edgar Link unprocessable
ie-20240331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ie-20240331_def.xml Edgar Link unprocessable